(Q43807982)

27 November 2017

Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile? (English)

1 reference

primary biliary cholangitis

27 November 2017

0 references

author name string

Angulo P

series ordinal

1

1 reference

27 November 2017

Jorgensen RA

series ordinal

2

1 reference

27 November 2017

Lindor KD

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

The American Journal of Gastroenterology

27 November 2017

1 reference

27 November 2017

96

1 reference

27 November 2017

11

1 reference

27 November 2017

3152-3157

1 reference

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

27 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05270.X

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05270.X

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05270.X

Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05270.X

Tauroursodeoxycholate prevents taurocholate induced cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05270.X

Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05270.X

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05270.X

Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05270.X

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05270.X

10.1111/J.1572-0241.2001.05270.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference